title: Pulmonary metastasis of giant cell tumor of bones.
abstract: Giant cell tumor of bone (GCTB) accounts for 5% of primary skeletal tumors. Although it is considered to be a benign lesion, there are still incidences of pulmonary metastasis. Pulmonary metastasis of GCTB may be affected by tumor grading and localization as well as the age, gender and overall health status of the patient. Patients with local recurrence are more likely to develop pulmonary metastasis of GCTB. High expression of some genes, cytokines and chemokines may also be closely related to the metastatic potential and prognosis of GCTB. The treatment of the primary GCTB is key to the final outcome of the disease, as intralesional curettage has a significantly higher local recurrence and pulmonary metastasis rate than wide resection. However, even patients with pulmonary metastasis seem to have a good prognosis after timely and appropriate surgical resection. It is hoped that with the development of novel surgical methods and drugs, pulmonary metastasis of GCTB can be prevented and treated more effectively.
authors.forename: Aikeremujiang
authors.initials: A
authors.lastname: Muheremu
authors.affiliation: Department of Orthopedic Oncology Surgery, Beijing Ji Shui Tan Hospital, 31 Xinjiekou East Street, 100035 Beijing, Xicheng District, China. niuxiaohui@263.net.
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Niu
mesh_terms: D001859:Bone Neoplasms / Q000473:pathology* / Q000601:surgery; D018212:Giant Cell Tumor of Bone / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary* / Q000601:surgery; D060787:Neoplasm Grading; D011379:Prognosis